Synthesis of 3-aroyl-4-aryl-1-isopropylamino-4-piperidinols and evaluation of the cytotoxicities of the compounds against human hepatoma and breast cancer cell lines

References

• Bange J, Zwick E, Ullrich A. Molecular targets for breast cancer therapy and prevention. Nat Med 2001;7:548–52
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108
   PubMed Web of Science ®Google Scholar
• Schwartz M, Roayaie S, Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol 2007;4:424–32
   PubMedGoogle Scholar
• Dimmock JR, Kumar P. Anticancer and cytotoxic properties of Mannich bases. Curr Med Chem 1997;4:1–22
   Web of Science ®Google Scholar
• Gul HI, Gul M, Vepsalainen J, et al. Cytotoxicity of some azines of acetophenone derived mono-Mannich bases against Jurkat cells. Biol Pharm Bull 2003;26:631–7
   PubMed Web of Science ®Google Scholar
• Gul M, Gul HI, Das U, Hanninen O. Biological evaluation and structure-activity relationships of bis-(3-aryl-3-oxo-propyl)-methylamine hydrochlorides and 4-aryl-3-arylcarbonyl-1-methyl-4-piperidinol hydrochlorides as potential cytotoxic agents and their alkylating ability towards cellular glutathione in human leukemic T cells. Arzneimittelforschung 2005;55:332–7
   PubMed Web of Science ®Google Scholar
• Gul M, Atalay M, Gul HI, et al. The effects of some Mannich bases on heat shock proteins HSC70 and GRP75, and thioredoxin and glutaredoxin levels in Jurkat cells. Toxicol In Vitro 2005;19:573–80
   PubMed Web of Science ®Google Scholar
• Gul HI, Yerdelen KO, Gul M, et al. Synthesis of 4′-hydroxy-3′-piperidinomethylchalcone derivatives and their cytotoxicity against PC-3 cell lines. Arch Pharm 2007;340:195–201
   PubMed Web of Science ®Google Scholar
• Gul HI, Yerdelen KO, Das U, et al. Synthesis and cytotoxicity of novel 3-aryl-1-(3′-dibenzylaminomethyl-4′-hydroxyphenyl)-propenones and related compounds. Chem Pharm Bull 2008;56:1675–81
   PubMed Web of Science ®Google Scholar
• Gul HI, Das U, Pandit B, Li PK. Evaluation of the cytotoxicity of some mono-Mannich bases and their corresponding azine derivatives against androgen-independent prostate cancer cells. Arzneimittelforschung 2006;56:850–5
   PubMed Web of Science ®Google Scholar
• Gul M, Mete E, Atalay M, et al. Cytotoxicity of 1-aryl-3-buthylamino-1-propanone hydrochlorides against Jurkat and L6 cells. Arzneimmittelforschung 2009;59:364–9
   PubMed Web of Science ®Google Scholar
• Mete E, Gul HI, Canturk P, et al. Biological activity of 1-aryl-3-phenethylamino-1-propanone hydrochlorides and 3-aroyl-4-aryl-1-phenethyl-4-piperidinols on PC-3 cells and DNA topoisomerase I enzyme. Z Naturforsch C 2010;65:647–52
   PubMed Web of Science ®Google Scholar
• Mete E, Gul HI, Cetin-Atalay R, et al. The design and cytotoxic evaluation of some 1-aryl-3-isopropylamino-1-propanone hydrochlorides towards human Huh-7 hepatoma cells. Arch Pharm Chem Life Sci 2011;344:333–9
   PubMed Web of Science ®Google Scholar
• Suleyman H, Gul HI, Gul M, et al. Anti-inflammatory activity of bis(3-aryl-3-oxo-propyl)methylamine hydrochloride in rat. Biol Pharm Bull 2007;30:63–7
   PubMed Web of Science ®Google Scholar
• Gul HI, Suleyman H, Gul M. Evaluation of the anti-inflammatory activity of N,N′-bis(3-dimethylamino-1-phenyl-propylidene) hydrazine dihydrochloride. Pharm Biol 2009;47:968–72
   Web of Science ®Google Scholar
• Sahin YN, Demircan B, Suleyman H, et al. The effects of 3-benzoyl-1-methyl-4-phenyl-4-piperidinolhydrochloride (C1), indomethacin, nimesulide and rofecoxib on cyclooxygenase activities in carrageenan-induced paw edema model. Turk J Med Sci 2010;40:723–8
   Web of Science ®Google Scholar
• Gul HI, Calis U, Vepsalainen J. Synthesis of some mono-Mannich bases and corresponding azine derivatives and evaluation of their anticonvulsant activity. Arzneimittelforschung 2004;54:359–64
   PubMed Web of Science ®Google Scholar
• Gul HI, Calls U, Ozturk Z, et al. Evaluation of anticonvulsant activities of bis(3-aryl-3-oxo-propyl) ethylamine hydrochlorides and 4-aryl-3-arylcarbonyl-1-ethyl-4-piperidinol hydrochlorides. Arzneimittelforschung 2007;57:133–6
   PubMed Web of Science ®Google Scholar
• Gul HI, Sahin F, Gul M, et al. Evaluation of antimicrobial activities of several Mannich bases and their derivatives. Arch Pharm 2005;338:335–8
   Web of Science ®Google Scholar
• Mete E, Ozelgul C, Kazaz C, et al. Synthesis and antifungal activity of 1-aryl-3-phenethylamino-1-propanone hydrochlorides and 3-aroyl-4-aryl-1-phenethyl-4-piperidinols. Arch Pharm 2010;343:291–300
   PubMed Web of Science ®Google Scholar
• Gul M, Gul HI, Hanninen O. Effects of Mannich bases on cellular glutathione and related enzymes of Jurkat cells in culture conditions. Toxicol In Vitro 2002;16:107–12
   PubMed Web of Science ®Google Scholar
• Gul M, Gul HI, Vepsalainen J, et al. Effect of acetophenone derived Mannich bases on cellular glutathione level in Jurkat cells. A possible mechanism of action. Arzneimittelforschung 2001;51:679–82
   PubMed Web of Science ®Google Scholar
• Sun D, Scherman MS, Jones V, et al. Discovery, synthesis, and biological evaluation of piperidinol analogs with anti-tuberculosis activity. Bioorg Med Chem 2009;17:3588–94
   PubMed Web of Science ®Google Scholar
• Suleyman H, Gul HI, Asoglu M. Anti-inflammatory activity of 3-benzoyl-1-methyl-4-phenyl-4-piperidinol hydrochloride. Pharmacol Res 2003;47:471–5
   PubMed Web of Science ®Google Scholar
• Anderson JT, Campbell M, Wang J, et al. Investigation of 4-piperidinols as novel H3 antagonists. Bioorg Med Chem Lett 2010;20:6246–9
   PubMed Web of Science ®Google Scholar
• Annoura H, Nakanishi K, Uesugi M, et al. Synthesis and biological evaluation of new 4-arylpiperidines and 4-aryl-4-piperidinols: dual Na(+) and Ca(2+) channel blockers with reduced affinity for dopamine D(2) receptors. Bioorg Med Chem 2002;10:371–83
   PubMed Web of Science ®Google Scholar
• Yang DR, Xue SJ, Wang HF, et al. Synthesis and anti-leukemia activity mensuration of 1-phenethyl-4-hydroxy-4-substituted piperidinium hydrochlorides: structure of bis[1-phenethyl-4-hydroxy-4-(3-fluorophenyl) piperidinium hydrochloride] studied by X-ray and DFT methods. J Mol Struct 2009;929:97–104
   Web of Science ®Google Scholar
• Yadav Y, MacLean ED, Bhattacharyya A, et al. Design, synthesis and bioevaluation of novel candidate selective estrogen receptor modulators. Eur J Med Chem 2011;46:3858–66
   PubMed Web of Science ®Google Scholar
• Wang S, Sakamuri S, Enyedy IJ, et al. Molecular modeling, structure–activity relationships and functional antagonism studies of 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketones as a novel class of dopamine transporter inhibitors. Bioorg Med Chem 2001;9:1753–64
   PubMed Web of Science ®Google Scholar
• Revesz L, Padova FED, Buhl T, et al. SAR of 4-hydroxypiperidine and hydroxyalkyl substituted heterocycles as novel p38 map kinase inhibitors. Bioorg Med Chem Lett 2000;10:1261–4
   PubMed Web of Science ®Google Scholar
• Vangveravong S, Taylor M, Xu J, et al. Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626. Bioorg Med Chem 2010;18:5291–300
   PubMed Web of Science ®Google Scholar
• Grundt P, Husband SLJ, Luedtke RR, et al. Analogues of the dopamine D2 receptor antagonist L741,626: binding, function, and SAR. Bioorg Med Chem Lett 2007;17:745–9
   PubMed Web of Science ®Google Scholar
• Kucukoglu K, Gul M, Atalay M, et al. Synthesis of some Mannich bases with dimethylamine and their hydrazones and evaluation of their cytotoxicity against Jurkat cells. Arzneim Forsch Drug Res 2011;61:366–71
   PubMed Web of Science ®Google Scholar
• Plati JT, Schmidt RA, Wenner W. 1,3,4-Trisubstituted piperidine derivatives from Mannich bases. J Org Chem 1949;14:873–8
   Web of Science ®Google Scholar
• Page W, Schevey WR, Vander Mey JE. Acidic zinc fluoborate electrolyte for a zinc electroplating process. US Patent No. 3655533, USA; 1972
   Google Scholar
• Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 2006;6:813–23
   PubMed Web of Science ®Google Scholar